TrimRx's Blog

Yes, in nearly all cases. Wegovy (semaglutide) does not have a clinically significant pharmacokinetic interaction with the common antibiotic classes.

Yes, women can take most of the peptides commonly used in men, including BPC-157, TB-500, ipamorelin, CJC-1295, and GLP-1 medications.

Calibrate and TrimRx draw very different reviews because they sell very different products. Calibrate is a year-long coaching-heavy program.

Introduction CagriSema is the cagrilintide 2.4 mg + semaglutide 2.4 mg fixed-dose combination that posted 22.7% mean weight loss in REDEFINE 1 (Novo Nordisk,…

Introduction CagriSema is the fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg, both peptide drugs, both unstable at room temperature for long…

Introduction CagriSema’s side effect profile combines the well-known GLP-1 class effects from semaglutide with additional amylin-related effects from cagrilintide. The REDEFINE 1 and 2…

CagriSema’s REDEFINE 1 phase 3 trial showed mean weight loss of about 22.7% at 68 weeks.

CagriSema is Novo Nordisk’s investigational weight management drug that combines two hormones in a single weekly injection.

CagriSema is the fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg developed by Novo Nordisk.